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In this issue Hay et al
1 report the results
of a randomised clinical trial evaluat-
ing the effectiveness of physiotherapy
and corticosteroid injection for patients
with unilateral shoulder pain. Shoulder
pain is a common complaint; estimates
of the annual incidence in general
practice vary from 6.6 to 25 cases per
1000 patients.2–4 Most patients are
treated in primary care. If treatment
with analgesics or non-steroidal anti-
inflammatory drugs (NSAIDs) is not
successful, patients with persistent
symptoms are often referred for physio-
therapy or treated with local infiltration
of a corticosteroid.4 Until recently, evi-
dence on the effectiveness of these inter-
ventions was scarce, particularly for pri-
mary care patients. Over the past few
years two randomised trials have been
published that directly compared the
effects of physiotherapy with cortico-
steroid injections.5 6 Both trials were car-
ried out in Dutch general practice.
The trial by Hay et al adds important
and relevant information to this existing
evidence. The trial is characterised by a
thorough design, enrolled a relatively
large number of patients, used relevant
outcome measures, and achieved a
nearly complete six months’ follow up of
participants. When examining the re-
sults of these three primary care trials,
three issues arise for discussion. Firstly,
the short term findings are rather differ-
ent, with the Dutch trials clearly show-
ing better effects of corticosteroid injec-
tions, whereas the English trial reports
similar outcomes for the two interven-
tions. Secondly, all three trials show
minor and non-significant differences at
long term follow up.1 6 7 Thirdly, the
somewhat ambiguous overall evidence
may leave substantial room for consider-
ing patient preferences and expectations
when applying the results in clinical
practice.
Inconsistent short term results:
differences in study group, content
of treatment, or outcome measures?
Figure 1a shows the self reported change
of symptoms at 5–7 weeks of follow up
for the three trials. As mentioned above,
the short term differences strongly fa-
vour injections in the Dutch trials,
whereas small, non-significant differ-
ences in the opposite direction are
reported for the English trial. This
heterogeneity in findings clearly exceeds
random variation, which is confirmed by
statistically testing for homogeneity
(χ2= 32.4, p<0.00001). It is of interest to
assess whether this heterogeneity can be
explained by differences in clinically rel-
evant factors, such as characteristics of
the patient group or content of
treatment.8 9 The trial by van der Windt et
al specifically selected patients with
restricted range of motion (painful and
stiff shoulder), and reported slightly
higher baseline scores for shoulder dis-
ability than the study by Hay et al. How-
ever, the three study groups are quite
similar in age, sex, duration of symp-
toms, presence of additional neck pain,
and severity of pain. Consequently, we
consider it unlikely that differences in
patient characteristics can explain the
heterogeneity in study results.
More obvious differences can be noted
about the content of treatment. In the
trial of Hay et al a single injection of
methylprednisolone was given, whereas
injection treatment in both Dutch trials
consisted of multiple (no more than
three) injections of triamcinolone over a
period of six weeks. Consequently, larger
treatment effects may be expected in
these two trials. However, fig 1a shows
very consistent success rates for injection
treatment: 73–76% of patients report
improvement of symptoms. There is
more variation across the trials in the
perceived benefit from physiotherapy,
with a relatively poor result in the trial by
Winters et al (20%), and a high success
rate in the trial by Hay et al (79%). How-
ever, there are, indeed, considerable
differences in the physiotherapy given
between the studies, as is discussed by
Hay et al. Do these differences explain the
different results for physiotherapy, and
does this mean that the physiotherapy
protocol used in the English trial is more
effective?
There may be another explanation for
the heterogeneity of results, related to
the definition of outcome. All three
studies evaluated self reported change,
but used different scales. Winters et al
used a dichotomous scale ("feeling
cured” or not), whereas the two other
trials used an ordinal five point or six
point scale. The only difference between
these latter scales is that van derWindt et
al included one additional response
Figure 1 Results of three randomised trials comparing the effects of corticosteroid injections and physiotherapy on self reported change in
patients with shoulder pain.1 5 6
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option—that is, “much improved” (sec-
ond to complete recovery). This differ-
ence may seem trivial, but when report-
ing success rates, these scales are often
dichotomised. The selection of a differ-
ent cut off point may have considerable
impact on the results of a trial, as fig 1b
shows. Of course, these results may be
unstable owing to the small proportion
of patients reporting full recovery, but
conclusions would have been rather dif-
ferent if the researchers had decided on
another definition of success.
In contrast with Hay et al, who
reported the results for the entire scale,
van der Windt et al only presented the
dichotomised outcome. We can assure
the reader that this cut off point was
defined before the start of the trial, and
already described in the grant proposal.
Furthermore, it was based on previous
research.10 None the less, the analyses
presented in fig 1 strongly argue against
the use of dichotomised outcomes with-
out consensus among trialists about the
definition of success or failure. Statistical
techniques are available that enable the
analysis of ordinal scales (for example,
ordinal regression), which could be used
in future analyses.
“Consensus on a core set of
outcome assessment measures is
needed”
Both trials also present the results for
shoulder disability, based on self com-
pleted questionnaires.1 6 However, differ-
ent questionnaires were used11 12 with a
different number of items, and different
concepts being measured. A comparison
of the results for shoulder disability can
be facilitated by computing standardised
mean differences (difference in mean
change scores in the compared groups
divided by their pooled standard
deviation).13 The results (fig 2) confirm
the better short term effect of cortico-
steroid injections in the Dutch study, and
the lack of difference in the English trial.
Again, this might have been influenced
by difference in the definition of out-
come measures: the Dutch questionnaire
strongly focuses on pain, whereas the
English questionnaire evaluates limita-
tions in activities (performance) in pa-
tients with shoulder pain.
Lack of differences in long term
outcome
There is insufficient evidence about the
long term effectiveness of injections or
physiotherapy compared with a wait and
see policy.14 15 The three trials described
here did not include such a control
group. Small and non-significant differ-
ences were reported between injections
and physiotherapy at 6–18 months’
follow up, although the results presented
by Hay et al seem to favour physio-
therapy, particularly for shoulder disabil-
ity and for the need for additional
co-intervention during follow up. As yet,
a cost effectiveness analysis has not yet
been published for any of the three trials.
The results of an economic evaluation
will be of interest. If physiotherapy is
successful in reducing medical con-
sumption and (work) disability, as the
results of Hay et al seem to suggest, these
benefits may outweigh the additional
costs of physiotherapy compared with
injections.
In their paper Hay et al rightly argue
that the results of the trials give patients
and primary care clinicians a clear choice
when deciding upon optimal treatment
for shoulder problems. Short term ben-
efits may be expected from cortico-
steroids (given the results of the Dutch
trials) particularly for reduction of pain,
but none of the treatments offer a clear
clinical long term advantage. Other
treatments are available to the general
practitioner that might be of help in
patients with shoulder pain, including
NSAIDs, physical applications (for ex-
ample, ultrasound, transcutaneous elec-
trical stimulation), or manual treatment.
Systematic reviews show that there is
lack of evidence about the effectiveness
of most interventions.14 15 Randomised
placebo controlled trials have demon-
strated better short term efficacy of
NSAIDs, but there is no information
about the benefit-risk ratio of NSAIDs
compared with simple analgesics for
shoulder pain. Furthermore, positive
results have been reported for manual
treatment as an addition to exercise
therapy in patients with subacromial
impingement syndrome,16 but this find-
ing needs further confirmation. Several
clinical guidelines for shoulder pain have
been published.17–19 Given the ambiguous
evidence, it is not surprising that some
recommendations of guidelines are not
consistent. The Dutch general practice
guideline more strongly advocates the
use of corticosteroid injections, when a
wait and see policy or drug treatment
has not been helpful,18 whereas the
guideline issued by the American Acad-
emy of Orthopedic Surgeons recom-
mends exercise programmes for most
patients with shoulder pain.19
Preferences and expectations
Patients differ in the way they experi-
ence pain, and in the way they respond
to treatment. Most patients will have
expectations about treatment that may
originate from previous experience, from
the influence of media, family or friends,
or from beliefs or worries.20 Such expec-
tations may be expressed as preferences
for a specific intervention in a trial.
“Patients’ expectations must be
taken into account when trials are
designed”
Previous research has shown that expec-
tations about treatment may influence
treatment outcome.21 22 In a randomised
clinical trial comparing the effectiveness
of acupuncture with massage in patients
with low back pain Kalauokalani et al
found greater improvement in disability
scores in patients with higher expecta-
tions about the allocated treatment.21
Figure 2 Results of two randomised trials comparing the effects of corticosteroid injections and physiotherapy on shoulder disability: short
term and long term outcome.1 6
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Similar results were found in the trial by
van der Windt et al.23
Being allocated to the preferred inter-
vention influenced success rate, but only
in patients allocated to injection treat-
ment. These findings indicate that it is
important to take patients’ expectations
into account when designing clinical
trials, particularly where blinding is diffi-
cult or impossible, or in trials in which
expectations or preferences may be
stronger for one of the interventions
under study.21 23 24 Although evidence is
not yet strong, clinicians should not
ignore the potential influence of expecta-
tions and preferences about treatment in
patients with musculoskeletal problems.
Given uncertain or equal effects, as is the
case in corticosteroid injection or physio-
therapy for shoulder pain, it is advisable to
explore and discuss any expectations and
preferences with the patient.
Conclusions
Randomised clinical trials on the effec-
tiveness of corticosteroid injections or
physiotherapy for shoulder pain in pri-
mary care show inconsistent short term
results. Differences in the content of
treatment may explain these differences,
but variation in selection and definition
of outcome measures may also be of
importance. Therefore, we agree with
Hay et al that is important to obtain con-
sensus on a core set of outcome meas-
ures for the assessment of shoulder pain,
as has, for example, been proposed for
low back pain research.25 Such a core set
will enable comparison of results across
studies, enhance the possibilities of
secondary pooled analyses and of meta-
analysis in systematic reviews, and facili-
tate the development of clinical practice
guidelines.
Evidence for the long term outcome of
physiotherapy or corticosteroid injec-
tions for shoulder pain is still limited.
The long term effectiveness and cost
effectiveness of both interventions need
further investigation. Future research
should also evaluate the potential influ-
ence of patient expectations and prefer-
ences on treatment outcome, particu-
larly when few differences in (cost-)
effectiveness are found, but strong dif-
ferences in expectations across treat-
ment options can be expected. This
certainly holds for the treatment of
shoulder pain in which interventions
vary considerably in their burden on the
patient, potential adverse reactions, and
costs.
Ann Rheum Dis 2003;0:385–387
. . . . . . . . . . . . . . . . . . . . .
Authors’ affiliations
REFERENCES
1 Hay EM, Thomas E, Paterson SM, Dzieczic K,
Croft PR. A pragmatic randomised controlled
trial of local corticosteroid injection and
physiotherapy for the treatment of new
episodes of unilateral shoulder pain in
primary care. Ann Rheum Dis
2003;62:394–9.
2 Croft P. Soft tissue rheumatism. In: Silman AJ,
Hochberg MC, eds. Epidemiology of the
rheumatic diseases. Oxford: Oxford Medical
Publications, 1993:375–421.
3 Lamberts H, Brouwer HJ, Mohrs J. Reason for
encounter-, episode- and process-oriented
standard output from transition project. Part I.
Amsterdam: Department of General
Practice/Family Medicine, University of
Amsterdam, 1991.
4 Van der Windt DAWM, Koes BW, De Jong
BA, Bouter LM. Shoulder disorders in general
practice: incidence, patient characteristics and
management. Ann Rheum Dis
1995;54:959–64.
5 Winters JC, Sobel JS, Groenier KH,
Arendzen HJ, Meyboom-de Jong B.
Comparison of physiotherapy, manipulation,
and corticosteroid injection for treating
shoulder complaints in general practice:
randomised, single blind study. BMJ
1997;314:1320–5.
6 Van der Windt DAWM, Koes BW, Boeke
AJP, Devillé W, De Jong BA, Bouter LM.
Corticosteroid injections versus physiotherapy
for painful stiff shoulder in primary care:
randomised trial. BMJ 1998;317:1292–6.
7 Winters JC, Jorritsma W, Groenier KH, Sobel
JS, Meyboom-de Jong B, Arendzen HJ.
Treatment of shoulder complaints in general
practice: long-term results of a randomised,
single blind study comparing physiotherapy,
manipulation, and corticosteroid injection.
BMJ 1999;31:1395–6.
8 Thompson SG. Why sources of heterogeneity
in meta-analysis should be investigated. BMJ
1994;309:1351–5.
9 Mulrow C, Langhorne P, Grimshaw J.
Integrating heterogeneous pieces of evidence
in systematic reviews. Ann Intern Med
1997;127:989–95.
10 Van der Windt DAWM, Van der Heijden
GJMG, Koes BW, De Winter AF, Devillé W,
Bouter LM. The responsiveness of the shoulder
disability questionnaire. Ann Rheum Dis
1998;57:82–7.
11 Croft P, Pope D, Zonca M, O’Neill T, Silman
A. Measurement of shoulder related disability:
results of a validation study. Ann Rheum Dis
1994;53:525–8.
12 Van der Heijden GJMG, Leffers P, Bouter
LM. Development and responsiveness of the
shoulder disability questionnaire. J Clin
Epidemiol 2000;53:29–38.
13 Cohen J. Statistical power analysis for the
behavioral sciences. 2nd ed. New Jersey:
Lawrence Erlbaum Associates, 1988.
14 Green S, Buchbinder R, Glazier R, Forbes A.
Systematic review of randomised controlled
clinical trials of interventions for painful
shoulder: selection criteria, outcome
assessment, and efficacy. BMJ
1998;316:354–60.
15 Speed CA, Hazleman BL. Shoulder pain. In:
Clinical evidence: a compendium of the best
available evidence for effective health care.
London: BMJ Publishing Group, 2000:issue 4.
16 Bang MD, Deyle GD. Comparison of
supervised exercise with and without manual
physical therapy for patients with shoulder
impingement syndrome. J Orthop Sports Phys
Ther 2000;30:126–37.
17 Philadelphia Panel. Evidence-based clinical
practice guidelines on selected rehabilitation
interventions for shoulder pain. Physical
Therapy 2001;81:1719–30.
18 Winters JC, De Jongh AC, Van der Windt
DAWM, Jonquière M, De Winter AF, Van der
Heijden GJMG, et al. General practice
guideline on shoulder complaints
[NHG-Standaard Schouderklachten]. Huisarts
& Wetenschap 1999;52:222–31.
19 AAOS. Clinical guideline on shoulder pain.
Rosemont, IL: American Academy of
Orthopedic Surgeons, 2001.
20 Till JE, Sutherland HJ, Meslin EM. Is there a
role for preference assessment in research on
quality of life in oncology? Qual Life Res
1992;1:31–40.
21 Kalauokalani D, Cherkin DC, Sherman KJ,
Koepsell TD, Deyo RA. Lessons from a trial of
acupuncture and massage for low back pain.
Patient expectations and treatment effects.
Spine 2001;26:1418–24.
22 Jackson JL, Kroenke K. The effect of unmet
expectations among adults presenting with
physical symptoms. Ann Intern Med
2001;134:889–97.
23 Van der Windt DAWM, Van Aarst M,
Heemskerk MAMB, Koes BW, Bouter LM.
Practical aspects of conducting a randomised
pragmatic trial in primary care: patient
recruitment and outcome assessment. Br J Gen
Pract 2000;50:371–4.
24 Lambert MF, Wood J. Incorporating patient
preferences into randomised trials. J Clin
Epidemiol 2000;53:163–6.
25 Deyo R, Battie M, Beurskens A, Bombardier
C, Croft P, Koes B, et al. Outcome measures
for low back pain research. A proposal
for standardised use. Spine
1998;23:2003–13.
LEADER 387
www.annrheumdis.com
